Catalyst
Slingshot members are tracking this event:
Phase 2 data of Ganaxolone for Fragile X Syndrome due 1Q 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MRNS | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 28, 2016
Occurred Source:
http://ir.marinuspharma.com/releasedetail.cfm?ReleaseID=977308
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fda, Ganaxolone, Phase 2, Fragile X Syndrome
